Salinomycin: a novel anti-cancer agent with known anti-coccidial activities.

Salinomycin, traditionally used as an anti-coccidial drug, has recently been shown to possess anti-cancer and anti-cancer stem cell (CSC) effects, as well as activities to overcome multi-drug resistance based on studies using human cancer cell lines, xenograft mice, and in case reports involving cancer patients in pilot clinical trials. Therefore, salinomycin may be considered as a promising novel anti-cancer agent despite its largely unknown mechanism of action. This review summarizes the pharmacologic effects of salinomycin and presents possible mechanisms by which salinomycin exerts its anti-tumorigenic activities. Recent advances and potential complications that might limit the utilization of salinomycin as an anti-cancer and anti-CSC agent are also presented and discussed.

[1]  Buzz Baum,et al.  Transitions between epithelial and mesenchymal states in development and disease. , 2008, Seminars in cell & developmental biology.

[2]  Hans Clevers,et al.  The cancer stem cell: premises, promises and challenges , 2011, Nature Medicine.

[3]  Eleonora Petrucci,et al.  The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. , 2010, Blood cells, molecules & diseases.

[4]  S. Legrand-Poels,et al.  NF-κB activation by reactive oxygen species: Fifteen years later , 2006 .

[5]  Yi Wang Effects of salinomycin on cancer stem cell in human lung adenocarcinoma A549 cells. , 2011, Medicinal chemistry (Shariqah (United Arab Emirates)).

[6]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[7]  Yang Liu,et al.  A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Hanson Lj,et al.  Toxic effects of lasalocid in horses. , 1981 .

[9]  O. Kallioniemi,et al.  Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress , 2012, British Journal of Cancer.

[10]  B. Brzeziński,et al.  Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic-salinomycin. , 2012, Bioorganic & medicinal chemistry letters.

[11]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[12]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[13]  Bei Zhang,et al.  Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK , 2012, Tumor Biology.

[14]  G. Opelz,et al.  Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. , 2010, Biochemical and biophysical research communications.

[15]  Fan Wang,et al.  Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[16]  G. Opelz,et al.  Salinomycin in cancer: A new mission for an old agent. , 2010, Molecular medicine reports.

[17]  B. Verdoodt,et al.  Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species , 2012, PloS one.

[18]  M. Mitani,et al.  Salinomycin: a new monovalent cation ionophore. , 1975, Biochemical and biophysical research communications.

[19]  A. Daugschies,et al.  Comparative efficacy of anticoccidials under the conditions of commercial broiler production and in battery trials. , 1998, Veterinary parasitology.

[20]  A. Ullrich,et al.  Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2‐positive cancer cells and cancer stem cells , 2012, International journal of cancer.

[21]  Soon-Cheol Ahn,et al.  Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. , 2011, Biochemical and biophysical research communications.

[22]  O. Crociani,et al.  Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. , 2009, Current medicinal chemistry.

[23]  S. Hackenberg,et al.  Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro. , 2013, Toxicology letters.

[24]  K. G. Magdesian,et al.  Salinomycin toxicosis in horses. , 2007, Journal of the American Veterinary Medical Association.

[25]  Novilla Mn,et al.  The comparative toxicology of narasin in laboratory animals , 1994 .

[26]  Sungpil Yoon,et al.  Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest , 2012, Investigational New Drugs.

[27]  Jos H. Beijnen,et al.  P-Glycoprotein Limits Oral Availability, Brain Penetration, and Toxicity of an Anionic Drug, the Antibiotic Salinomycin , 2007, Antimicrobial Agents and Chemotherapy.

[28]  Jun Yin,et al.  Salinomycin inhibits osteosarcoma by targeting its tumor stem cells. , 2011, Cancer letters.

[29]  Zhiwei Wang,et al.  NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases , 2008, International reviews of immunology.

[30]  D. Johnson,et al.  Salinomycin residues and their ionophoricity in pig tissues , 1990 .

[31]  T. Kang,et al.  Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. , 2011, Cancer letters.

[32]  G. Weinstein,et al.  Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas , 2011, Cell cycle.

[33]  M. Zheng,et al.  Salinomycin Selectively Targets ‘CD133+’ Cell Subpopulations and Decreases Malignant Traits in Colorectal Cancer Lines , 2011, Annals of Surgical Oncology.

[34]  B. Brzeziński,et al.  Antiproliferative activity of salinomycin and its derivatives. , 2012, Bioorganic & medicinal chemistry letters.

[35]  Cord Naujokat,et al.  Salinomycin as a Drug for Targeting Human Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.

[36]  Qiang Zhang,et al.  The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. , 2012, Biomaterials.

[37]  T. Kipps,et al.  Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells , 2011, Proceedings of the National Academy of Sciences.

[38]  R. Aydın,et al.  Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting. , 2013, Journal of biomedical materials research. Part A.

[39]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[40]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[41]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[42]  B. Kerr,et al.  The efficacy of salinomycin as a growth promotant for swine from 9 to 97 kg. , 1985, Journal of animal science.

[43]  N. Ōtake,et al.  Salinomycin Effects on Mitochondrial Ion Translocation and Respiration , 1976, Antimicrobial Agents and Chemotherapy.

[44]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[45]  M. Goodell,et al.  A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Beynen,et al.  Salinomycin-induced Polyneuropathy in Cats: Morphologic and Epidemiologic Data , 1999, Veterinary pathology.

[47]  Pier Paolo Di Fiore,et al.  The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells , 2009, Cell.

[48]  M. Laurentie,et al.  Comparison of the oral bioavailability and tissue disposition of monensin and salinomycin in chickens and turkeys. , 2012, Journal of veterinary pharmacology and therapeutics.

[49]  Y. Jung,et al.  Ionophores: their use as ruminant growth promotants and impact on food safety. , 2003, Current issues in intestinal microbiology.

[50]  F. Galey,et al.  Acute Salinomycin Toxicosis of Pigs , 1995, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[51]  C. Stock,et al.  Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. , 2013, Cancer research.

[52]  M. D. Ruff,et al.  Anticoccidial activity of salinomycin in floor-pen experiments with broilers. , 1977, Poultry science.

[53]  J. Klempnauer,et al.  Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro , 2012, BMC Cancer.

[54]  G. Opelz,et al.  Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. , 2009, Biochemical and biophysical research communications.

[55]  W. Gerald,et al.  Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling , 2011, Nature communications.

[56]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[57]  S. Esumi,et al.  Salinomycin, a new polyether antibiotic. , 1974, The Journal of antibiotics.

[58]  Adam Huczyński Salinomycin – A New Cancer Drug Candidate , 2012, Chemical biology & drug design.

[59]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[60]  A. Doube,et al.  A case of human poisoning by salinomycin, an agricultural antibiotic. , 2004, The New Zealand medical journal.

[61]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[62]  Sungpil Yoon,et al.  Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein , 2011, British journal of pharmacology.

[63]  F. Haesebrouck,et al.  Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria , 2003, Clinical Microbiology Reviews.

[64]  J. Ji,et al.  Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[65]  Sungpil Yoon,et al.  Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest. , 2012, Biochemical and biophysical research communications.

[66]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[67]  B. Rubin,et al.  Kitlow stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors. , 2010, Gastroenterology.

[68]  Synan F. AbuQamar,et al.  Salinomycin induces apoptosis and senescence in breast cancer: upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation. , 2013, Biochimica et biophysica acta.

[69]  Ramón García-Domenech,et al.  Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening. , 2006, The Journal of antimicrobial chemotherapy.

[70]  M. Endres,et al.  Salinomycin induces calpain and cytochrome c-mediated neuronal cell death , 2011, Cell Death and Disease.